153 related articles for article (PubMed ID: 28962520)
1. Editor's Highlight: Complete Attenuation of Mouse Lung Cell Proliferation and Tumorigenicity in CYP2F2 Knockout and CYP2F1 Humanized Mice Exposed to Inhaled Styrene for up to 2 Years Supports a Lack of Human Relevance.
Cruzan G; Bus JS; Banton MI; Sarang SS; Waites R; Layko DB; Raymond J; Dodd D; Andersen ME
Toxicol Sci; 2017 Oct; 159(2):413-421. PubMed ID: 28962520
[TBL] [Abstract][Full Text] [Related]
2. Studies of styrene, styrene oxide and 4-hydroxystyrene toxicity in CYP2F2 knockout and CYP2F1 humanized mice support lack of human relevance for mouse lung tumors.
Cruzan G; Bus J; Hotchkiss J; Sura R; Moore C; Yost G; Banton M; Sarang S
Regul Toxicol Pharmacol; 2013 Jun; 66(1):24-9. PubMed ID: 23454103
[TBL] [Abstract][Full Text] [Related]
3. Strain-related differences in mouse lung gene expression over a two-year period of inhalation exposure to styrene: Relevance to human risk assessment.
Andersen ME; Cruzan G; Black MB; Pendse SN; Dodd DE; Bus JS; Sarang SS; Banton MI; Waites R; Layko DB; McMullen PD
Regul Toxicol Pharmacol; 2018 Jul; 96():153-166. PubMed ID: 29777725
[TBL] [Abstract][Full Text] [Related]
4. CYP2F2-generated metabolites, not styrene oxide, are a key event mediating the mode of action of styrene-induced mouse lung tumors.
Cruzan G; Bus J; Hotchkiss J; Harkema J; Banton M; Sarang S
Regul Toxicol Pharmacol; 2012 Feb; 62(1):214-20. PubMed ID: 22041433
[TBL] [Abstract][Full Text] [Related]
5. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.
Cruzan G; Bus J; Banton M; Gingell R; Carlson G
Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367
[TBL] [Abstract][Full Text] [Related]
6. Based on an analysis of mode of action, styrene-induced mouse lung tumors are not a human cancer concern.
Cruzan G; Bus JS; Andersen ME; Carlson GP; Banton MI; Sarang SS; Waites R
Regul Toxicol Pharmacol; 2018 Jun; 95():17-28. PubMed ID: 29496518
[TBL] [Abstract][Full Text] [Related]
7. Chronic toxicity/oncogenicity study of styrene in CD-1 mice by inhalation exposure for 104 weeks.
Cruzan G; Cushman JR; Andrews LS; Granville GC; Johnson KA; Bevan C; Hardy CJ; Coombs DW; Mullins PA; Brown WR
J Appl Toxicol; 2001; 21(3):185-98. PubMed ID: 11404830
[TBL] [Abstract][Full Text] [Related]
8. Critical appraisal of the expression of cytochrome P450 enzymes in human lung and evaluation of the possibility that such expression provides evidence of potential styrene tumorigenicity in humans.
Carlson GP
Toxicology; 2008 Dec; 254(1-2):1-10. PubMed ID: 18951947
[TBL] [Abstract][Full Text] [Related]
9. The role of cytochromes P-450 in styrene induced pulmonary toxicity and carcinogenicity.
Green T; Toghill A; Foster JR
Toxicology; 2001 Dec; 169(2):107-17. PubMed ID: 11718952
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the mode of action of mouse lung tumors induced by 4-methylimidazole.
Cruzan G; Harkema JR; Hosako H; Wasil JM; Murray FJ
Regul Toxicol Pharmacol; 2015 Nov; 73(2):501-8. PubMed ID: 26456664
[TBL] [Abstract][Full Text] [Related]
11. Styrene respiratory tract toxicity and mouse lung tumors are mediated by CYP2F-generated metabolites.
Cruzan G; Carlson GP; Johnson KA; Andrews LS; Banton MI; Bevan C; Cushman JR
Regul Toxicol Pharmacol; 2002 Jun; 35(3):308-19. PubMed ID: 12202046
[TBL] [Abstract][Full Text] [Related]
12. Assessing molecular initiating events (MIEs), key events (KEs) and modulating factors (MFs) for styrene responses in mouse lungs using whole genome gene expression profiling following 1-day and multi-week exposures.
Andersen ME; Cruzan G; Black MB; Pendse SN; Dodd D; Bus JS; Sarang SS; Banton MI; Waites R; McMullen PD
Toxicol Appl Pharmacol; 2017 Nov; 335():28-40. PubMed ID: 28951217
[TBL] [Abstract][Full Text] [Related]
13. Modification of the metabolism and toxicity of styrene and styrene oxide in hepatic cytochrome P450 reductase deficient mice and CYP2F2 deficient mice.
Carlson GP
Toxicology; 2012 Apr; 294(2-3):104-8. PubMed ID: 22386858
[TBL] [Abstract][Full Text] [Related]
14. Relationship of Metabolism and Cell Proliferation to the Mode of Action of Fluensulfone-Induced Mouse Lung Tumors. II: Additional Mechanistic Studies.
Strupp C; Bomann W; Cohen SM; Weber K
Toxicol Sci; 2016 Dec; 154(2):296-308. PubMed ID: 27605420
[TBL] [Abstract][Full Text] [Related]
15. Procedural application of mode-of-action and human relevance analysis: styrene-induced lung tumors in mice.
Frank EA; Meek MEB
Crit Rev Toxicol; 2024 Feb; 54(2):134-151. PubMed ID: 38440945
[TBL] [Abstract][Full Text] [Related]
16. DNA adducts of styrene-7,8-oxide in target and non-target organs for tumor induction in rat and mouse after repeated inhalation exposure to styrene.
Otteneder M; Lutz U; Lutz WK
Mutat Res; 2002 Mar; 500(1-2):111-6. PubMed ID: 11890940
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of a CYP2A13/2B6/2F1-transgenic mouse model.
Wei Y; Wu H; Li L; Liu Z; Zhou X; Zhang QY; Weng Y; D'Agostino J; Ling G; Zhang X; Kluetzman K; Yao Y; Ding X
Drug Metab Dispos; 2012 Jun; 40(6):1144-50. PubMed ID: 22397853
[TBL] [Abstract][Full Text] [Related]
18. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
[TBL] [Abstract][Full Text] [Related]
19. A toxicokinetic model for styrene and its metabolite styrene-7,8-oxide in mouse, rat and human with special emphasis on the lung.
Csanády GA; Kessler W; Hoffmann HD; Filser JG
Toxicol Lett; 2003 Feb; 138(1-2):75-102. PubMed ID: 12559694
[TBL] [Abstract][Full Text] [Related]
20. NTP toxicology and carcinogensis studies of vanadium pentoxide (CAS No. 1314-62-1) in F344/N rats and B6C3F1 mice (inhalation).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2002 Dec; (507):1-343. PubMed ID: 12533744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
